7,376.86

+23.13

+0.31%

51,285.73

-237.33

-0.46%

24,579.42

+264.43

+1.09%

2,754.11

+24.22

+0.89%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,074.90

-38.60

-0.94%

75,663.08

-67.97

-0.09%

Crude Oil Dec 26

90.83

+0.31

+0.34%

US Private Equity

10,772.76

+11.83

+0.11%

HKSE - Delayed Quote HKD

Tianjin TEDA Biomedical Engineering Company Limited (8189.HK)

0.130 +0.007 (+5.69%)

At close: November 6 at 4:08:50 PM GMT+8

Loading Chart for 8189.HK

Chart Range Bar

Interval:

In partnership with ChartIQ

DRDGOLD And 2 Top Gold Stocks To Watch

DRDGOLD And 2 Top Gold Stocks To Watch

Dow Jones Futures: Market Needs Repair But Apple, Amazon, Microsoft Strong; Berkshire Doubles Stock Buyback

Dow Jones Futures: Market Needs Repair But Apple, Amazon, Microsoft Strong; Berkshire Doubles Stock Buyback

Devon Energy Stock And Other Oil Producers Facing Inflation Pressure

Devon Energy Stock And Other Oil Producers Facing Inflation Pressure

Berkshire Surprised With Record Buybacks, but Pace Slowed as the Stock Rose

Berkshire Surprised With Record Buybacks, but Pace Slowed as the Stock Rose

Consumer Staples Showdown: Weighing the Differences Between VDC and RSPS

Consumer Staples Showdown: Weighing the Differences Between VDC and RSPS

Forget the AI Friday Rally: Why Big Money Is Still Fleeing to Warren Buffett’s Berkshire Hathaway

Forget the AI Friday Rally: Why Big Money Is Still Fleeing to Warren Buffett’s Berkshire Hathaway

Bitcoin Has Traded at a Discount on Coinbase for 61 Straight Days. Have U.S. Investors Stopped Buying BTC?

Bitcoin Has Traded at a Discount on Coinbase for 61 Straight Days. Have U.S. Investors Stopped Buying BTC?

NIKE (NKE) Could Be 6% Undervalued On Analyst Downgrades And Reset Risks

NIKE (NKE) Could Be 6% Undervalued On Analyst Downgrades And Reset Risks

What Kimbell Royalty (KRP) Said on Its Q3 Earnings Call

What Kimbell Royalty (KRP) Said on Its Q3 Earnings Call

This Warren Buffett Dividend Stock Is the One I'd Buy With $1,000 in November

This Warren Buffett Dividend Stock Is the One I'd Buy With $1,000 in November

Wall Street Is Ignoring Bristol Myers Squibb's Cash Machine -- and That's an Opportunity for Income Investors

Wall Street Is Ignoring Bristol Myers Squibb's Cash Machine -- and That's an Opportunity for Income Investors

Mobilize your Website

View Site in Mobile | Classic

Share by: